Inhibition of IKKβ by celastrol and its analogues – an in silico and in vitro approach

References

• Abbas S, Bhoumik A, Dahl R, Vasile S, Krajewski S, Cosford ND, Ronai ZA. 2007. Preclinical studies of celastrol and acetyl isogambogic acid in melanoma. Clin Cancer Res. 13:6769–6778.
   PubMed Web of Science ®Google Scholar
• Barger SW, Hörster D, Furukawa K, Goodman Y, Krieglstein J, Mattson MP. 1995. Tumor necrosis factors alpha and beta protect neurons against amyloid beta-peptide toxicity: evidence for involvement of a kappa B-binding factor and attenuation of peroxide and Ca2+ accumulation. Proc Natl Acad Sci USA. 92:9328–9332.
   PubMed Web of Science ®Google Scholar
• Barger SW, Mattson MP. 1996. Induction of neuroprotective kappa B-dependent transcription by secreted forms of the Alzheimer's beta-amyloid precursor. Brain Res Mol Brain Res. 40:116–126.
   PubMedGoogle Scholar
• Barzilai J, Borwein JM. 1988. Two-point step size gradient methods. IMA J Numer Anal. 8:141–148.
   Web of Science ®Google Scholar
• Castello MA, Jeppson JD, Soriano S. 2014. Moving beyond anti-amyloid therapy for the prevention and treatment of Alzheimer's disease. BMC Neurol. 14:169.
   PubMed Web of Science ®Google Scholar
• Cleren C, Calingasan NY, Chen J, Beal MF. 2005. Celastrol protects against MPTP- and 3-nitropropionic acid-induced neurotoxicity. J Neurochem. 94:995–1004.
   PubMed Web of Science ®Google Scholar
• Fiala M, Lin J, Ringman J, Kermani-Arab V, Tsao G, Patel A, Lossinsky AS, Graves MC, Gustavson A, Sayre J. 2005. Ineffective phagocytosis of amyloid-beta by macrophages of Alzheimer's disease patients. J Alzheimers Dis. 7:221–232.
   PubMed Web of Science ®Google Scholar
• Ganesan A. 2008. The impact of natural products upon modern drug discovery. Curr Opin Chem Biol. 12:306–317.
   PubMed Web of Science ®Google Scholar
• Giacobini E, Gold G. 2013. Alzheimer disease therapy-moving from amyloid-β to tau. Nat Rev Neurol. 9:677–686.
   PubMed Web of Science ®Google Scholar
• Gilmore TD. 2006. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene. 25:6680–6684.
   PubMed Web of Science ®Google Scholar
• Glass CK, Saijo K, Winner B, Marchetto MC, Gage FH. 2010. Mechanisms underlying inflammation in neurodegeneration. Cell. 140:918–934.
   PubMed Web of Science ®Google Scholar
• Granic I, Dolga AM, Nijholt IM, van Dijk G, Eisel UL. 2009. Inflammation and NF-kappaB in Alzheimer's disease and diabetes. J Alzheimers Dis. 16:809–821.
   PubMed Web of Science ®Google Scholar
• Hardy J, Selkoe DJ. 2002. The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics. Science. 297:353–356.
   PubMed Web of Science ®Google Scholar
• Harvey AL. 2008. Natural products in drug discovery. Drug Discov Today. 13:894–901.
   PubMed Web of Science ®Google Scholar
• Hayden M, West A, Ghosh S. 2006. NF-kappaB and the immune response. Oncogene. 25:6758–6780.
   PubMed Web of Science ®Google Scholar
• Hickman SE, Allison EK, El Khoury J. 2008. Microglial dysfunction and defective beta-amyloid clearance pathways in aging Alzheimer's disease mice. J Neurosci. 28:8354–8360.
   PubMed Web of Science ®Google Scholar
• Hou T, Wang J, Zhang W, Wang W, Xu X. 2006. Recent advances in computational prediction of drug absorption and permeability in drug discovery. Curr Med Chem. 13:2653–2667.
   PubMed Web of Science ®Google Scholar
• Kannaiyan R, Shanmugam MK, Sethi G. 2011. Molecular targets of celastrol derived from Thunder of God Vine: potential role in the treatment of inflammatory disorders and cancer. Cancer Lett. 303:9–20.
   PubMed Web of Science ®Google Scholar
• Kiaei M, Kipiani K, Petri S, Chen J, Calingasan NY, Beal MF. 2005. Celastrol blocks neuronal cell death and extends life in transgenic mouse model of amyotrophic lateral sclerosis. Neurodegener Dis. 2:246–254.
   PubMed Web of Science ®Google Scholar
• Lagunin A, Filimonov D, Poroikov V. 2010. Multi-targeted natural products evaluation based on biological activity prediction with PASS. Curr Pharm Des. 16:1703–1717.
   PubMed Web of Science ®Google Scholar
• Lee J-H, Koo TH, Yoon H, Jung HS, Jin HZ, Lee K, Hong Y-S, Lee JJ. 2006. Inhibition of NF-kappa B activation through targeting I kappa B kinase by celastrol, a quinone methide triterpenoid. Biochem Pharmacol. 72:1311–1321.
   PubMed Web of Science ®Google Scholar
• Lipinski CA. 2004. Lead- and drug-like compounds: the rule-of-five revolution. Drug Discov Today Technol. 1:337–341.
   PubMedGoogle Scholar
• Liu S, Misquitta YR, Olland A, Johnson MA, Kelleher KS, Kriz R, Lin LL, Stahl M, Mosyak L. 2013. Crystal structure of a human IκB kinase β asymmetric dimer. J Biol Chem. 288:22758–22767.
   PubMed Web of Science ®Google Scholar
• Lucin KM, Wyss-Coray T. 2009. Immune activation in brain aging and neurodegeneration: too much or too little? Neuron. 64:110–122.
   PubMed Web of Science ®Google Scholar
• Mattson MP, Camandola S. 2001. NF-kappaB in neuronal plasticity and neurodegenerative disorders. J Clin Invest. 107:247–254.
   PubMed Web of Science ®Google Scholar
• Moroy G, Martiny VY, Vayer P, Villoutreix BO, Miteva MA. 2012. Toward in silico structure-based ADMET prediction in drug discovery. Drug Discov Today. 17:44–55.
   PubMed Web of Science ®Google Scholar
• Mushtaq G, Khan JA, Kumosani TA, Kamal MA. 2015. Alzheimer's disease and type 2 diabetes via chronic inflammatory mechanisms. Saudi J Biol Sci. 22:4–13.
   PubMed Web of Science ®Google Scholar
• Paris D, Ganey NJ, Laporte V, Patel NS, Beaulieu-Abdelahad D, Bachmeier C, March A, Ait-Ghezala G, Mullan MJ. 2010. Reduction of beta-amyloid pathology by celastrol in a transgenic mouse model of Alzheimer's disease. J Neuroinflammation. 7:17.
   PubMed Web of Science ®Google Scholar
• Perkins ND. 2007. Integrating cell-signalling pathways with NF-kappaB and IKK function. Nat Rev Mol Cell Biol. 8:49–62.
   PubMed Web of Science ®Google Scholar
• Poroikov VV, Filimonov DA, Ihlenfeldt WD, Gloriozova TA, Lagunin AA, Borodina YV, Stepanchikova AV, Nicklaus MC. 2003. PASS biological activity spectrum predictions in the enhanced open NCI database browser. J Chem Inf Comput Sci. 43:228–236.
   PubMedGoogle Scholar
• Raja SM, Clubb RJ, Ortega-Cava C, Williams SH, Bailey TA, Duan L, Zhao X, Reddi AL, Nyong AM, Natarajan A, et al. 2011. Anticancer activity of celastrol in combination with ErbB2-targeted therapeutics for treatment of ErbB2-overexpressing breast cancers. Cancer Biol Ther. 11:263–276.
   PubMed Web of Science ®Google Scholar
• Rappe AK, Casewit CJ, Colwell KS, Goddard WA, Skiff WM. 1992. UFF, a full periodic table force field for molecular mechanics and molecular dynamics simulations. J Am Chem Soc. 114:10024–10035.
   Web of Science ®Google Scholar
• Sastre M, Walter J, Gentleman SM. 2008. Interactions between APP secretases and inflammatory mediators. J Neuroinflammation. 5:25
   PubMed Web of Science ®Google Scholar
• Serrano-Pozo A, Frosch MP, Masliah E, Hyman BT. 2011. Neuropathological alterations in Alzheimer disease. Cold Spring Harb Perspect Med. 1(1):a006189.
   Web of Science ®Google Scholar
• Siraj FM, Natarajan S, Kim YJ, Chun Yang D. 2015. In silico screening of ginsenoside Rh1 with PPARγ and in vitro analysis on 3T3-L1 cell line. Mol Simulation. 41:1219–1226.
   Web of Science ®Google Scholar
• Sterck HD. 2013. Steepest descent preconditioning for nonlinear GMRES optimization. Numer. Linear Algebra Appl. 20:453–471.
   Web of Science ®Google Scholar
• Sun H, Xu L, Yu P, Jiang J, Zhang G, Wang Y. 2010. Synthesis and preliminary evaluation of neuroprotection of celastrol analogues in PC12 cells. Bioorg Med Chem Lett. 20:3844–3847.
   PubMedGoogle Scholar
• Tang K, Huang Q, Zeng J, Wu G, Huang J, Pan J, Lu W. 2014. Design, synthesis and biological evaluation of C6-modified celastrol derivatives as potential antitumor agents. Molecules. 19:10177–10188.
   PubMed Web of Science ®Google Scholar
• Tang WJ, Wang J, Tong X, Shi JB, Liu XH, Li J. 2015. Design and synthesis of celastrol derivatives as anticancer agents. Eur J Med Chem. 95:166–173.
   PubMed Web of Science ®Google Scholar
• Trott O, Olson AJ. 2010. AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem. 31:455–461.
   PubMed Web of Science ®Google Scholar
• Vehmas AK, Kawas CH, Stewart WF, Troncoso JC. 2003. Immune reactive cells in senile plaques and cognitive decline in Alzheimer's disease. Neurobiol Aging. 24:321–331.
   PubMed Web of Science ®Google Scholar
• Wan Y, Xu J, Meng F, Bao Y, Ge Y, Lobo N, Vizcaychipi MP, Zhang D, Gentleman SM, Maze M. 2010. Cognitive decline following major surgery is associated with gliosis, β-amyloid accumulation, and τ phosphorylation in old mice. Crit Care Med. 38:2190–2198.
   PubMed Web of Science ®Google Scholar
• Wang R, Lai L, Wang S. 2002. Further development and validation of empirical scoring functions for structure-based binding affinity prediction. J Comput Aided Mol Des. 16:11–26.
   PubMed Web of Science ®Google Scholar
• Wang W-Y, Tan M-S, Yu J-T, Tan L. 2015. Role of pro-inflammatory cytokines released from microglia in Alzheimer's disease. Ann Transl Med. 3:136.
   PubMed Web of Science ®Google Scholar
• Wolber G, Langer T. 2005. LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. J Chem Inf Model. 45:160–169.
   PubMed Web of Science ®Google Scholar
• Wolf LK. 2009. Digital briefs. Chem Eng News. 87:48.
   Google Scholar
• Yamamoto M, Kiyota T, Walsh SM, Liu J, Kipnis J, Ikezu T. 2008. Cytokine-mediated inhibition of fibrillar amyloid-beta peptide degradation by human mononuclear phagocytes. J Immunol. 181:3877–3886.
   PubMed Web of Science ®Google Scholar
• Zelcer N, Khanlou N, Clare R, Jiang Q, Reed-Geaghan EG, Landreth GE, Vinters HV, Tontonoz P. 2007. Attenuation of neuroinflammation and Alzheimer's disease pathology by liver x receptors. Proc Natl Acad Sci USA. 104:10601–10606.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Zhao H, Lobo N, Guo X, Gentleman SM, Ma D. 2014. Celastrol enhances cell viability and inhibits amyloid-β production induced by lipopolysaccharide in vitro. J Alzheimers Dis. 41:835–844.
   PubMed Web of Science ®Google Scholar
• Zotova E, Nicoll JA, Kalaria R, Holmes C, Boche D. 2010. Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy. Alzheimers Res Ther. 2:1.
   PubMed Web of Science ®Google Scholar